Insulinotropic action of a new sulfonylurea: gliclazide.
D000818:Animals; D003517:Cyclopentanes / Q000494:pharmacology; D003925:Diabetic Angiopathies / Q000517:prevention & control; D004285:Dogs; D004347:Drug Interactions; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000494:pharmacology; D005905:Glyburide / Q000494:pharmacology; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D010179:Pancreas / Q000187:drug effects*; D011758:Pyrroles / Q000494:pharmacology; D051381:Rats; D013453:Sulfonylurea Compounds / Q000494:pharmacology*
D003517:Cyclopentanes; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D011758:Pyrroles; D013453:Sulfonylurea Compounds; D005947:Glucose; D005905:Glyburide